Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report published on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA opened at $0.00 on Friday. Calithera Biosciences has a one year low of $0.00 and a one year high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.